Pulmonary Arterial Hypertension in France
This contemporary registry highlights current practice and shows that PAH is detected late in the course of the disease, with a majority of patients displaying severe functional...
Publications
2 shownPulmonary hypertension associated with benfluorex exposure
Benfluorex was marketed in France until 2009, despite its similar pharmacological properties with fenfluramine and its derivatives known to be a cause of pulmonary arterial hype...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,068
- Institution
- Assistance Publique – Hôpitaux de Paris
External Links
Identifiers
- ORCID
- 0000-0002-5236-5867
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.